Kenneth Finegold, PhD

Kenneth Finegold, PhD, is Senior Vice President of Research and Policy at the National Pharmaceutical Council (NPC).

At NPC, he applies his deep knowledge of the research and evidence used to support federal policymaking to drive NPC’s research. His areas of focus include mandatory international reference pricing, the Inflation Reduction Act (IRA), the 340B Program, and Pharmacy Benefit Managers (PBMs). He also works across the NPC team to share NPC’s research related to policy through comment letters and educational initiatives.

Dr. Finegold was previously a Senior Social Science Analyst in the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation (ASPE), where he led the Office of Health Policy Drug Pricing Team. He served at HHS for over 15 years and worked on health policy research related to the Department’s implementation of significant legislation including the Affordable Care Act and the Inflation Reduction Act. Prior to HHS, he was a Senior Research Associate at the Urban Institute.

Dr. Finegold has received numerous awards for his work. At HHS, he was part of four teams that won the top Departmental Award recognizing exceptional contributions, the Secretary’s Award for Excellence (two for work on drug pricing and two for work on coverage). He was part of one team that won the second-highest award at HHS, the Secretary’s Award for Meritorious Service. He also received the Alliance for Health Policy’s Unsung Hero Award in 2019. 

Dr. Finegold has a PhD in Political Science from Harvard and an AB in Government from Cornell. He and his family live in Wilmington, Delaware.